Dublin, April 04, 2017 -- Research and Markets has announced the addition of the "Defibrillator Devices Global Market - Forecast to 2023" report to their offering.
The Defibrillator Devices Global Market is Expected to Grow at a Mid to High Single Digit CAGR to Reach $17,710.8 Million by 2023
Among the defibrillator devices products market implantable cardioverter defibrillators segment holds the largest share of the market and external defibrillators is expected to be the fastest growing segment. In applications market ventricular tachycardia holds the largest share of the market and ventricular fibrillation is expected to grow with a strong CAGR from 2016 to 2023. In end-users, hospitals are the largest segment and home healthcare is the fastest growing segment from 2016 to 2023.
Geographically, North America is the largest market followed by Europe and Asia Pacific. The APAC region is the fastest growing region from 2016 to 2023 presenting an array of opportunities for growth and is likely to get attention of new investors in the defibrillator devices market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The defibrillator devices market is expected to grow at a single high digit CAGR during 2016 to 2023. Increase in aging population and subsequent rise in incidence of cardiovascular diseases, increasing use of defibrillators in public access areas and favorable reimbursement policies are the factors driving the market growth. Increasing trend of MRI compatible defibrillators, emergence of next generation integrated ICD's and market expansion opportunities in emerging nations are expected to offer potential opportunities.
However, various factors like patient safety risks due to chances of infection and other complications while using defibrillators, lack of awareness on sudden cardiac arrests limit the growth of defibrillator devices global market. The threats for the defibrillator devices market include lack of cybersecurity in ICD's and increasing number of defibrillator device recalls due to FDA mandates.
Factors Influencing Market
Drivers and Opportunities
- Increase in Aging Population and Subsequent Rise in Incidence of Cardiovascular Diseases
- Increasing Use of Defibrillators in Public Access Areas
- Favorable Reimbursement Policies
- Emergence of Next Generation Integrated ICD's
- Increasing Trend for MRI Compatible Defibrillators
- Market Expansion Opportunities in Emerging Nations
Restraints and Threats
- Patient Safety Risks Due to Chances of Infections and Other Complications While Using Defibrillators
- Lack of Awareness on Sudden Cardiac Arrests
- Lack of Cybersecurity in ICD's
- Increasing Number of Defibrillator Devices Product Recalls Due to Fda Mandates
Companies Mentioned
- 3B Scientific GmbH
- A.M.I. Italia S.R.L
- Abbott Laboratories
- Allied Medical Limited
- Asahi Kasei Corporation
- Bexen Cardio
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- BPL Medical Technologies
- Corpuls
- CU Medical Systems Inc
- Cura Healthcare Pvt Ltd
- Dixion Vertrieb Medizinischer Geräte GmbH
- Electromedicals
- Emtel Sliwa SP.K.
- Fukuda Denshi
- Gaumard Scientific
- HD1PY
- Innomed Medical Developing and Manufacturing
- Instramed
- Integer Holdings Corporation
- Life Plus Medical Inc
- Lifebot
- Livanova Plc
- M&B Electronic Instruments
- Mediana
- Medical Econet GmbH
- Meditech
- Medtronic Plc
- Metrax GmbH
- Metsis Medikal
- Mindray
- Minnesota Wire
- MS Westfalia GmbH
- Nanoomtech
- Narang Medical Limited
- Nasan Medical Electronics Pvt Ltd
- Nihon Kohden Corporation
- Orientmed International FZE
- Philips Healthcare
- Promed Co Ltd
- Rapid Diagnostics Pvt Ltd
- Ritim Grup AS
- Rotaid
- Schiller
- Shenzhen XFT Electronics
- Simulaids
- Stryker Corporation
- Techno-Gaz
- US Defib Medical Technologies
- Weinmann Emergency Medical Technology
- Xincheng Scientific Industries Co., Ltd.
- Yuan Technology Limited
For more information about this report visit http://www.researchandmarkets.com/research/npr6b3/defibrillator
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Cardiovascular Devices


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Instagram Outage Disrupts Thousands of U.S. Users
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



